These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2519860)

  • 1. An in vivo human tumor xenograft model of etoposide resistance.
    Rose WC; Basler GA
    In Vivo; 1989; 3(4):249-53. PubMed ID: 2519860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
    Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of KW2149, a new mitomycin derivative, administered by different modalities.
    Nishiyama M; Kim R; Jinushi K; Takagami S; Kirihara Y; Toge T
    In Vivo; 1989; 3(6):375-9. PubMed ID: 2519881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mitomycin on human colon carcinoma cells.
    Long BH; Willson JK; Brattain DE; Musial S; Brattain MG
    J Natl Cancer Inst; 1984 Oct; 73(4):787-92. PubMed ID: 6434780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of growth and metastases of human colon cancer xenograft in nude mice by angiogenesis inhibitor endostatin].
    Zhang GF; Wang YH; Zhang MA; Wang Q; Luo YB; Wang DS; Han CR
    Ai Zheng; 2002 Jan; 21(1):50-3. PubMed ID: 12500397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents.
    Aamdal S; Fodstad O; Pihl A
    Anticancer Res; 1985; 5(4):329-37. PubMed ID: 4037730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
    Willson JK; Long BH; Chakrabarty S; Brattain DE; Brattain MG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5281-6. PubMed ID: 3931904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil treatment of a human colon adenocarcinoma implanted in the subrenal capsule site of athymic mice.
    Zimmerman RJ; VanWinkle TJ; Mantel N; Frei E; Goldin A
    Cancer Res; 1986 Feb; 46(2):694-700. PubMed ID: 3940636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution, DNA damage and cytotoxic effects of etoposide in human tumor xenografts in vivo.
    Ullmann CA; Eliot HM; Sinha BK
    Anticancer Res; 1991; 11(4):1379-82. PubMed ID: 1746894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.
    Willson JK; Long BH; Marks ME; Brattain DE; Wiley JE; Brattain MG
    Cancer Res; 1984 Dec; 44(12 Pt 1):5880-5. PubMed ID: 6437674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.
    Golas JM; Lucas J; Etienne C; Golas J; Discafani C; Sridharan L; Boghaert E; Arndt K; Ye F; Boschelli DH; Li F; Titsch C; Huselton C; Chaudhary I; Boschelli F
    Cancer Res; 2005 Jun; 65(12):5358-64. PubMed ID: 15958584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
    Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.